According to Iran's Tasnim News Agency, amidst a tight blockade of oil trade, a high-tech economy has reversed the situation; products the size of a few medicine vials can generate added value equivalent to tens of thousands of barrels of crude oil, and due to their biological nature, they are practically immune to sanctions. Iran has risen to eighth globally in stem cell production, second globally in its national umbilical cord blood storage network, and among the top five globally in eye stem cell transplantation, signifying its strategic transformation from hydrocarbons to biotechnology. This transformation has safeguarded the country's foreign exchange balance and economic resilience at the most critical geopolitical juncture. Now, with the acquisition of the most authoritative international certifications such as EU Good Manufacturing Practices (EU-GMP) and the European Medicines Agency (EMA), this deterrent force has been transformed into geoeconomic leverage.
